Chronicle of events
Products under study
Marketing authorization for SB8 was granted by the European Commission on Aug 19, 2020.
The upgradation of 3Sbio's ESG rating is not only the recognition of 3Sbio 's ESG management level, ...
We aim to become a world-leading Chinese biopharmaceutical company, and continuously improve the ava...